Literature DB >> 25848346

Epidemiology and Clinical Research Design, Part 1: Study Types.

Veena Manja1, Satyan Lakshminrusimha2.   

Abstract

Selecting the best available preventive and therapeutic measures to avoid disability and death is an important goal for all health care practitioners. To achieve this goal, we need to perform studies that determine the value of these measures. In this article, we discuss the possible study designs that can be used for evaluating new approaches to prevention and treatment. The gold standard study design is a randomized, controlled, double-blind trial. In many instances, a randomized controlled trial may not be ethically or practically feasible. Other study types, such as case series, case-control studies, cohort studies, cross-sectional studies, crossover designs, and open-label studies, may be required to hypothesize and evaluate the link between an exposure or predictor variable and an outcome variable. Various study types pertaining to neonatal-perinatal medicine are reviewed in this article.

Entities:  

Year:  2014        PMID: 25848346      PMCID: PMC4384651          DOI: 10.1542/neo.15-12-e558

Source DB:  PubMed          Journal:  Neoreviews        ISSN: 1526-9906


  6 in total

1.  Research and statistics: a question of time: cross-sectional versus longitudinal study designs.

Authors:  Sarah Lindstrom Johnson
Journal:  Pediatr Rev       Date:  2010-06

2.  Research and statistics: case reports, anecdotal evidence, and descriptive epidemiologic studies in pediatric practice.

Authors:  Eva M Moore; Sara B Johnson
Journal:  Pediatr Rev       Date:  2009-08

3.  Research and statistics: cohort studies.

Authors:  Raquel G Hernandez; Peter C Rowe
Journal:  Pediatr Rev       Date:  2009-09

4.  Research and statistics: case-control studies.

Authors:  Krishna Upadhya; Peter Rowe
Journal:  Pediatr Rev       Date:  2010-02

5.  Acquired immune deficiency syndrome in the United States: the first 1,000 cases.

Authors:  H W Jaffe; D J Bregman; R M Selik
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

6.  Association between caffeine citrate exposure and necrotizing enterocolitis in preterm infants.

Authors:  Stacie J Lampkin; Ann Marie Turner; Satyan Lakshminrusimha; Bobby Mathew; Jack Brown; Cory E Fominaya; Kristin K Johnson
Journal:  Am J Health Syst Pharm       Date:  2013-04-01       Impact factor: 2.637

  6 in total
  13 in total

1.  Hospitalizations and in-hospital outcomes in patients with ST-elevation myocardial infarction during the coronavirus disease 2019 pandemic: The Albanian experience.

Authors:  Leonard Simoni; Ilir Alimehmeti; Mirald Gina; Astrit Ceka; Ermir Tafaj; Alban Dibra; Artan Goda
Journal:  Anatol J Cardiol       Date:  2022-02       Impact factor: 1.596

2.  Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review.

Authors:  Mia Evans; Ria Gill; Kim S Bull
Journal:  Neurooncol Adv       Date:  2022-06-24

3.  When is an outbreak an outbreak? Using literature and discharge data to define Clostridioides difficile incidence changes referred to as outbreaks.

Authors:  C C Cohen; G Azhar; L Muggy
Journal:  J Hosp Infect       Date:  2020-03-20       Impact factor: 3.926

4.  Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.

Authors:  James S Yeh; Ameet Sarpatwari; Aaron S Kesselheim
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

5.  Gender Differences in Admissions and In-Hospital Outcomes of Patients With Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic.

Authors:  Leonard Simoni; Ilir Alimehmeti; Astrit Ceka; Mirald Gina; Ermir Tafaj; Alban Dibra; Artan Goda
Journal:  Cureus       Date:  2022-03-18

Review 6.  Evaluating the efficacy of bronchoscopy for the diagnosis of early stage lung cancer.

Authors:  David M DiBardino; Anil Vachani; Lonny Yarmus
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

7.  Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review.

Authors:  Lucas Chun Wah Fong; Thomas J Ford; Bruno R da Costa; Peter Jüni; Colin Berry
Journal:  J Am Heart Assoc       Date:  2020-07-09       Impact factor: 5.501

8.  Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19.

Authors:  Mohammad Bosaeed; Ahmad Alharbi; Mohammad Hussein; Mohammed Abalkhail; Khizra Sultana; Abrar Musattat; Hajar Alqahtani; Majid Alshamrani; Ebrahim Mahmoud; Adel Alothman; Abdulrahman Alsaedy; Omar Aldibasi; Khalid Alhagan; Abdullah Mohammed Asiri; Sameera AlJohani; Majed Al-Jeraisy; Ahmed Alaskar
Journal:  BMJ Open       Date:  2021-04-14       Impact factor: 2.692

9.  A Systematic Review of Randomized Controlled Trials of Antibiotic Use in Diabetic Foot Ulcer Infections: Focus on Clinical Cure.

Authors:  Vincent Pratama; Hindun Wilda Risni; Em Yunir; Rani Sauriasari
Journal:  Infect Chemother       Date:  2022-03

10.  Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.

Authors:  Jonathan Barratt; Wladyslaw Sulowicz; Michael Schömig; Ciro Esposito; Michael Reusch; James Young; Botond Csiky
Journal:  Adv Ther       Date:  2021-09-14       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.